Use of Existing Patient-Reported Outcome (PRO) Instruments and Their Modification: The ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification PRO Task Force Report

Margaret Rothman(Janssen (United States)), Charles D. Petrie(Pfizer (United States)), Donald L. Patrick(Donaldson (United States)), Laurie B. Burke(Center for Drug Evaluation and Research), Pennifer Erickson, Nancy Kline Leidy(Health Outcomes Solutions (United States))
Value in Health
September 25, 2009
10.1111/j.1524-4733.2009.00603.x
Cited by 461

Related Papers

Development and first validation of the COPD Assessment Test
|European Respiratory Journal|2009|3.2k
Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 2—Assessing Respondent Understanding
|Value in Health|2011|1.1k
Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 1—Eliciting Concepts for a New PRO Instrument
|Value in Health|2011|1.1k
GRADE guidelines: 13. Preparing Summary of Findings tables and evidence profiles—continuous outcomes
|Journal of Clinical Epidemiology|2012|761
Assessment of Health-Related Quality of Life in Children: A Review of Conceptual, Methodological, and Regulatory Issues
|Value in Health|2004|695